{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:27:01Z","timestamp":1778678821023,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation","award":["2023GXNSFAA026262"],"award-info":[{"award-number":["2023GXNSFAA026262"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Saudi Pharm. J."],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s44446-026-00065-3","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T09:23:48Z","timestamp":1772529828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of renal function parameters and acute kidney injury incidence between vancomycin monotherapy and vancomycin-fosfomycin combination therapy in patients: a propensity score-matched analysis"],"prefix":"10.1007","volume":"34","author":[{"given":"Lan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7817-7254","authenticated-orcid":false,"given":"Yue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"issue":"3","key":"65_CR1","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1016\/s1473-3099(23)00432-2","volume":"24","author":"S Alosaimy","year":"2024","unstructured":"Alosaimy S, Rybak MJ, Sakoulas G (2024) Understanding vancomycin nephrotoxicity augmented by \u03b2-lactams: a synthesis of endosymbiosis, proximal renal tubule mitochondrial metabolism, and \u03b2-lactam chemistry. Lancet Infect Dis 24(3):e179\u2013e188. https:\/\/doi.org\/10.1016\/s1473-3099(23)00432-2","journal-title":"Lancet Infect Dis"},{"key":"65_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/cc2872","author":"R Bellomo","year":"2004","unstructured":"Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, the ADQI workgroup (2004) Acute renal failure \u2013 definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. https:\/\/doi.org\/10.1186\/cc2872","journal-title":"Crit Care"},{"issue":"2","key":"65_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1128\/cmr.00068-15","volume":"29","author":"ME Falagas","year":"2016","unstructured":"Falagas ME, Vouloumanou EK, Samonis G, Vardakas KZ (2016) Fosfomycin. Clin Microbiol Rev 29(2):321\u2013347. https:\/\/doi.org\/10.1128\/cmr.00068-15","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"65_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s40121-019-00278-1","volume":"9","author":"SCJ Jorgensen","year":"2020","unstructured":"Jorgensen SCJ, Murray KP, Lagnf AM et al (2020) A multicenter evaluation of vancomycin-associated acute kidney injury in hospitalized patients with acute bacterial skin and skin structure infections. Infect Dis Ther 9(1):89\u2013106. https:\/\/doi.org\/10.1007\/s40121-019-00278-1","journal-title":"Infect Dis Ther"},{"issue":"4","key":"65_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042052","volume":"23","author":"W-C Kan","year":"2022","unstructured":"Kan W-C, Chen Y-C, Wu V-C, Shiao C-C (2022) Vancomycin-associated acute kidney injury: a narrative review from pathophysiology to clinical application. Int J Mol Sci 23(4):2052. https:\/\/doi.org\/10.3390\/ijms23042052","journal-title":"Int J Mol Sci"},{"issue":"4","key":"65_CR6","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120(4):c179\u2013c184. https:\/\/doi.org\/10.1159\/000339789","journal-title":"Nephron Clin Pract"},{"issue":"4","key":"65_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/bf01642811","volume":"13","author":"R Marre","year":"1985","unstructured":"Marre R, Schulz E, Hedtke D, Sack K (1985) Influence of fosfomycin and tobramycin on vancomycin-induced nephrotoxicity. Infection 13(4):190\u2013192. https:\/\/doi.org\/10.1007\/bf01642811","journal-title":"Infection"},{"key":"65_CR8","unstructured":"M\u00fa\u00f1ez Rubio E, Ramos Mart\u00ednez A, Fern\u00e1ndez Cruz A (2019) Fosfomycin in antimicrobial stewardship programs. Rev Esp Quimioter 32 Suppl 1(Suppl1):62\u201366. Accessed July 21, 2025. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6555160\/"},{"issue":"3","key":"65_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295136","volume":"19","author":"R Nachiappa Ganesh","year":"2024","unstructured":"Nachiappa Ganesh R, Edwards A, El Zaatari Z, Gaber L, Barrios R, Truong LD (2024) Vancomycin nephrotoxicity: a comprehensive clinico-pathological study. PLoS ONE 19(3):e0295136. https:\/\/doi.org\/10.1371\/journal.pone.0295136","journal-title":"PLoS ONE"},{"issue":"2","key":"65_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1211\/0022357991772187","volume":"51","author":"T Nakamura","year":"1999","unstructured":"Nakamura T, Kokuryo T, Hashimoto Y, Inui K-I (1999) Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats. J Pharm Pharmacol 51(2):227\u2013232. https:\/\/doi.org\/10.1211\/0022357991772187","journal-title":"J Pharm Pharmacol"},{"issue":"03","key":"65_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5414\/cpp39121","volume":"39","author":"N Rojanasthien","year":"2001","unstructured":"Rojanasthien N, Kumsorn B, Atikachai B, Leotrakul S, Thongprasert S (2001) Protective effects of fosfomycin on Cisplatin- induced nephrotoxicity in patients with lung cancer. Int J Clin Pharmacol Ther 39(03):121\u2013125. https:\/\/doi.org\/10.5414\/cpp39121","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"65_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/jac\/dkac380","volume":"78","author":"LD Saravolatz","year":"2023","unstructured":"Saravolatz LD, Pawlak J (2023) In vitro activity of fosfomycin alone and in combination against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid. J Antimicrob Chemother 78(1):238\u2013241. https:\/\/doi.org\/10.1093\/jac\/dkac380","journal-title":"J Antimicrob Chemother"},{"key":"65_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-018-0845-1","author":"A Sawada","year":"2018","unstructured":"Sawada A, Kawanishi K, Morikawa S et al (2018) Biopsy-proven vancomycin-induced acute kidney injury: a case report and literature review. BMC Nephrol. https:\/\/doi.org\/10.1186\/s12882-018-0845-1","journal-title":"BMC Nephrol"},{"issue":"91","key":"65_CR14","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1288\/00005537-198609000-00005","volume":"96","author":"VG Schweitzer","year":"1986","unstructured":"Schweitzer VG, Dolan DF, Abrams GE, Davidson T, Snyder R (1986) Amelioration of cisplatin-induced ototoxicity by fosfomycin. Laryngoscope 96(91):948\u2013958. https:\/\/doi.org\/10.1288\/00005537-198609000-00005","journal-title":"Laryngoscope"},{"issue":"12","key":"65_CR15","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.2215\/cjn.05920616","volume":"11","author":"A Sinha Ray","year":"2016","unstructured":"Sinha Ray A, Haikal A, Hammoud KA, Yu ASL (2016) Vancomycin and the risk of AKI: a systematic review and meta-analysis. Clin J Am Soc Nephrol 11(12):2132\u20132140. https:\/\/doi.org\/10.2215\/cjn.05920616","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"65_CR16","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1097\/00005537-200007000-00029","volume":"110","author":"JR Tandy","year":"2000","unstructured":"Tandy JR, Tandy RD, Farris P, Truelson JM (2000) In vivo interaction of Cis\u2010platinum and fosfomycin on squamous cell carcinoma. Laryngoscope 110(7):1222\u20131224. https:\/\/doi.org\/10.1097\/00005537-200007000-00029","journal-title":"Laryngoscope"},{"issue":"11","key":"65_CR17","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/s0025-6196(12)65799-1","volume":"66","author":"MP Wilhelm","year":"1991","unstructured":"Wilhelm MP (1991) Vancomycin. Mayo Clin Proc 66(11):1165\u20131170. https:\/\/doi.org\/10.1016\/s0025-6196(12)65799-1","journal-title":"Mayo Clin Proc"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44446-026-00065-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44446-026-00065-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44446-026-00065-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:38:34Z","timestamp":1778675914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44446-026-00065-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["65"],"URL":"https:\/\/doi.org\/10.1007\/s44446-026-00065-3","relation":{},"ISSN":["1319-0164","2213-7475"],"issn-type":[{"value":"1319-0164","type":"print"},{"value":"2213-7475","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the study participants signed an informed consent for the inclusion in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University (Approval No 2025-E0613).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"10"}}